Connect
MJA
MJA

Misleading advertising of PI-based drug information?*

Jim R Stockigt
Med J Aust 2008; 188 (11): . || doi: 10.5694/j.1326-5377.2008.tb01839.x
Published online: 2 June 2008

* It should be noted that the question mark in the title was added at the Editor's discretion.


  • 1 Epworth Hospital, Melbourne, VIC.
  • 2 Department of Endocrinology and Diabetes, The Alfred Hospital, Melbourne, VIC.
  • 3 Monash University, Melbourne, VIC.


Correspondence: jrs@netspace.net.au

  • 1. Medicines Australia code of conduct: breaches. Australian Prescriber 2007; 30: 153-155.
  • 2. Stockigt JR. Barriers in the quest for quality drug information: salutary lessons from TGA-approved sources for thyroid-related medications. Med J Aust 2007; 186: 76-79. <MJA full text>
  • 3. Barriers in the quest for quality drug information: salutary lessons from TGA-approved sources for thyroid-related medications [matters arising]. Med J Aust 2007; 186: 483-485. <MJA full text>
  • 4. Dowden JS. Product information past perfect [editorial]. Med J Aust 2007; 186: 51-52. <MJA full text>

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.